| Code: MTA13308 | Publication Date: Jul 2026 |
The following is a data-backed list of the leading South Korea Turner Syndrome companies, compiled through 6Wresearch's proprietary research and validated by in-house industry analysts. These companies represent the key players shaping competition in the South Korea Turner Syndrome Industry, including LG Chem, Novo Nordisk Korea, and other established names.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full South Korea Turner Syndrome Industry.
| Company Name | LG Chem |
|---|---|
| Established Year | 1947 (Group) |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Pioneered domestic growth hormone development in South Korea, supplying advanced therapeutic pens to manage short stature in paediatric patients.
| Company Name | Novo Nordisk Korea |
|---|---|
| Established Year | 1994 (Local Subsidiary) |
| Headquarters | Bagsvaerd, Denmark (Regional Hub: Seoul) |
| Official Website | Click Here |
Provides critical rare disease treatments and growth hormone therapies such as Norditropin to support pediatric endocrine disorders nationwide.
| Company Name | Pfizer Korea |
|---|---|
| Established Year | 1959 (in Korea) |
| Headquarters | New York, USA (Regional Hub: Seoul) |
| Official Website | Click Here |
Delivers established biopharmaceutical portfolios and specialized hormone treatments assisting healthcare professionals managing complex genetic conditions.
| Company Name | Merck Korea |
|---|---|
| Established Year | 1989 (in Korea) |
| Headquarters | Darmstadt, Germany (Regional Hub: Seoul) |
| Official Website | Click Here |
Supplies specialized healthcare solutions and therapeutic options supporting specialized clinical endocrinology and metabolic care networks.
| Company Name | Dong-A ST |
|---|---|
| Established Year | 2013 (Spin-off) |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Advances domestic clinical research and local distribution for specialized biopharmaceuticals, including biosimilar growth hormone therapies.
| Company Name | Merck Sharp & Dohme (MSD Korea) |
|---|---|
| Established Year | 1984 (in Korea) |
| Headquarters | Rahway, USA (Regional Hub: Seoul) |
| Official Website | Click Here |
Offers innovative prescription medicines and biological treatments aiding specialized physicians in managing pediatric growth failure.
| Company Name | Ferring Pharmaceuticals Korea |
|---|---|
| Established Year | 2008 (Local Subsidiary) |
| Headquarters | Saint-Prex, Switzerland (Regional Hub: Seoul) |
| Official Website | Click Here |
Focuses on specialized endocrine and reproductive health treatments, addressing unique developmental care requirements for patients.
| Company Name | Handok Inc. |
|---|---|
| Established Year | 1954 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Collaborates with global healthcare leaders to distribute specialized rare disease medications and therapeutic solutions across domestic hospitals.
| Company Name | Yuhan Corporation |
|---|---|
| Established Year | 1926 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Maintains robust nationwide distribution networks delivering essential specialty pharmaceuticals and endocrine treatments to medical clinics.
| Company Name | Hanmi Pharm |
|---|---|
| Established Year | 1973 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Drives local pharmaceutical research and commercialization of specialized therapeutic formulations addressing complex metabolic and growth needs.